Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 26  •  02:13PM ET
35.92
Dollar change
-1.09
Percentage change
-2.95
%
May 21, 10:50 PMMedline prices upsized 72.6M-share secondary Class A offering at $37 by existing PE shareholders
Index
-
P/E
30.04
EPS (ttm)
1.20
Insider Own
42.38%
Shs Outstand
846.00M
Perf Week
-0.28%
Market Cap
47.19B
Forward P/E
21.68
EPS next Y
1.66
Insider Trans
-31.47%
Shs Float
487.83M
Perf Month
-19.75%
Enterprise Value
65.66B
PEG
2.26
EPS next Q
0.32
Inst Own
62.44%
Perf Quarter
-28.15%
Income
966.00M
P/S
1.62
EPS this Y
5.55%
Inst Trans
9.30%
Perf Half Y
-
Sales
29.14B
P/B
2.70
EPS next Y
9.69%
ROA
3.11%
Perf YTD
-14.48%
Book/sh
13.32
P/C
21.08
EPS next 5Y
9.59%
ROE
8.50%
52W High
50.88 -29.40%
Perf Year
-
Cash/sh
1.70
P/FCF
45.16
EPS past 3/5Y
- -
ROIC
4.06%
52W Low
34.89 2.95%
Perf 3Y
-
EV/EBITDA
20.71
Sales past 3/5Y
9.85% -
Gross Margin
23.44%
Volatility
4.51% 4.55%
Perf 5Y
-
EV/Sales
2.25
EPS Y/Y TTM
-22.07%
Oper. Margin
7.39%
ATR (14)
1.79
Perf 10Y
-
Quick Ratio
2.51
Sales Y/Y TTM
12.07%
Profit Margin
3.32%
RSI (14)
31.83
Current Ratio
4.41
EPS Q/Q
-62.12%
SMA20
-10.35%
Beta
-
Debt/Eq
1.12
Sales Q/Q
10.66%
SMA50
-16.04%
Rel Volume
1.53
Prev Close
37.01
Employees
45000
LT Debt/Eq
1.11
SMA200
-17.48%
Avg Volume
7.81M
Price
35.92
IPO
Dec 17, 2025
Option/Short
Yes / Yes
Trades
Volume
8,834,852
Change
-2.95%
Date Action Analyst Rating Change Price Target Change
Mar-11-26Resumed Citigroup Buy $60
Feb-05-26Initiated Tigress Financial Buy $55
Jan-21-26Reiterated BTIG Research Buy $50 → $55
Jan-12-26Initiated Wolfe Research Outperform $47
Jan-12-26Initiated William Blair Outperform
Jan-12-26Initiated Wells Fargo Equal Weight $42
Jan-12-26Initiated UBS Buy $48
Jan-12-26Initiated Truist Buy $52
Jan-12-26Initiated TD Cowen Buy $46
Jan-12-26Initiated Stifel Buy $46
May-21-26 10:45PM
May-20-26 03:56PM
07:10AM
May-18-26 05:42PM
May-07-26 02:16PM
07:40AM Loading…
May-06-26 07:40AM
07:30AM
May-04-26 04:30PM
Apr-21-26 08:38AM
Apr-20-26 11:18AM
Apr-16-26 03:41PM
Apr-09-26 01:36PM
Apr-08-26 09:00AM
Apr-06-26 03:11PM
Apr-03-26 02:55PM
03:29PM Loading…
Apr-01-26 03:29PM
Mar-11-26 02:00PM
07:45AM
06:00AM
Mar-10-26 02:00PM
Mar-09-26 08:14PM
11:47AM
Mar-04-26 08:00PM
Mar-03-26 10:20AM
07:02AM
Feb-27-26 05:13PM
Feb-26-26 08:02PM
06:00AM
Feb-25-26 03:29PM
03:18PM
11:30AM Loading…
11:30AM
07:47AM
07:30AM
05:46AM
Feb-24-26 12:31PM
Feb-20-26 08:00AM
Feb-19-26 02:55PM
Feb-18-26 07:30AM
Feb-13-26 01:11PM
Feb-10-26 12:00AM
Feb-06-26 10:10AM
Feb-05-26 01:35AM
Jan-30-26 01:37AM
Jan-28-26 09:00AM
Jan-22-26 07:21AM
03:10AM
Jan-16-26 08:28PM
06:00AM
Jan-14-26 09:31AM
Jan-13-26 10:39AM
Jan-12-26 01:59PM
09:49AM
08:07AM
02:00AM
Jan-10-26 02:24PM
Dec-30-25 04:05PM
08:45AM
Dec-23-25 02:23PM
Dec-22-25 07:17AM
Dec-21-25 10:07AM
Dec-19-25 10:09AM
Dec-18-25 04:13PM
04:05PM
03:13PM
05:46AM
Dec-17-25 04:07PM
04:03PM
04:01PM
02:19PM
01:39PM
01:07PM
11:04AM
11:04AM
11:04AM
Dec-16-25 06:00PM
Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.
CEO & DirectorMr. James M. Boyle
Chief Financial OfficerMr. Michael B. Drazin
Chief Operating OfficerMr. Stephen L. Miller
Chief Commercial OfficerMr. Douglas P. Golwas
Chief Accounting OfficerMs. Jessi L. Corcoran
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hellman & Friedman Capital Par10% OwnerMar 10 '26Sale40.5126,131,2371,058,524,148558,307Mar 12 08:01 PM
Carlyle Group Inc.10% OwnerMar 10 '26Sale41.0026,105,8401,070,339,440127,567,724Mar 12 04:30 PM
Carlyle Mozart Coinvestment Ho10% OwnerMar 10 '26Sale41.0026,105,8401,070,339,440127,567,724Mar 12 04:30 PM
CP Circle ML Holdco GP, LLC10% OwnerMar 10 '26Sale41.0026,105,8401,070,339,440127,567,724Mar 12 04:30 PM
TC Group Cayman Investment Hol10% OwnerMar 10 '26Sale41.0026,105,8401,070,339,440127,567,724Mar 12 04:30 PM
BCP 8 Holdings Mozart Manager 10% OwnerMar 10 '26Sale40.5127,852,9861,128,268,7571,539Mar 12 04:15 PM
BX Mozart ML-2 Holdco L.P.10% OwnerMar 10 '26Sale40.5127,852,9861,128,268,7571,539Mar 12 04:15 PM
Hellman & Friedman Capital Par10% OwnerDec 18 '25Sale28.376,088,371172,716,7354,806,160Dec 22 09:57 PM
GIC Private Ltd10% OwnerDec 18 '25Buy29.0012,586,206364,999,97427,241,378Dec 22 05:26 PM
GIC Private Ltd10% OwnerDec 18 '25Sale28.3710,204,351289,480,09091,555,447Dec 22 05:26 PM
TC Group VII S1, L.L.C.10% OwnerDec 18 '25Sale29.0019,136,333554,953,657145,924,924Dec 22 04:30 PM
Carlyle Mozart Coinvestment Ho10% OwnerDec 18 '25Sale29.0019,136,333554,953,657145,924,924Dec 22 04:30 PM
Carlyle Group Inc.10% OwnerDec 18 '25Sale29.0019,136,333554,953,657145,924,924Dec 22 04:30 PM
Mozart Aggregator II LP10% OwnerDec 18 '25Sale28.3713,462,600381,911,076143,187,216Dec 22 04:30 PM
Mills Andrew J.DirectorDec 18 '25Buy29.002,586,20674,999,9742,586,206Dec 22 04:30 PM
Mills Charles N.DirectorDec 18 '25Buy29.002,579,31074,799,9902,441,379Dec 22 04:30 PM